E-ISSN 2305-1620 | ISSN 2221-0288
 
2025, Vol: 15, Issue: 1
15 / 1Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Title page (Sample)

Editorial
Online Published: 05 Jan 2025
 


Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments

Warda Ahmad, Muhammad Babar Imran.


Abstract
Novel targeted therapies tailored to the molecular profile of tumors have revolutionized the treatment landscape for advanced radioiodine-refractory differentiated thyroid cancer (RAI-R DTC), showcasing notable progression-free survival rates. These emerging therapies, leveraging kinase inhibitors, exhibit a remarkable capacity to restore iodide uptake in RAI-R thyroid cancer cells. However, successful implementation relies on crucial factors like adopting a multidisciplinary team approach and timely initiation of targeted therapies.

Key words: Multidisciplinary team, Progression-free survival, Targeted therapies, Thyroid cancer.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Warda Ahmad
Articles by Muhammad Babar Imran
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ahmad W, Imran MB. Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments. Pak J Nucl Med. 2024; 14(2): 38-40. doi:10.24911/PJNMed.175-1715857171

Web Style

Ahmad W, Imran MB. Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments. https://www.pjnmed.com/?mno=201941 [Access: June 28, 2026]. doi:10.24911/PJNMed.175-1715857171

AMA (American Medical Association) Style

Ahmad W, Imran MB. Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments. Pak J Nucl Med. 2024; 14(2): 38-40. doi:10.24911/PJNMed.175-1715857171


Vancouver/ICMJE Style

Ahmad W, Imran MB. Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments. Pak J Nucl Med. (2024), [cited June 28, 2026]; 14(2): 38-40. doi:10.24911/PJNMed.175-1715857171


Harvard Style

Ahmad, W. & Imran, . M. B. (2024) Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments. Pak J Nucl Med, 14 (2), 38-40. doi:10.24911/PJNMed.175-1715857171


Turabian Style

Ahmad, Warda, and Muhammad Babar Imran. 2024. Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments. Pakistan Journal of Nuclear Medicine, 14 (2), 38-40. doi:10.24911/PJNMed.175-1715857171


Chicago Style

Ahmad, Warda, and Muhammad Babar Imran. "Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments." Pakistan Journal of Nuclear Medicine 14 (2024), 38-40. doi:10.24911/PJNMed.175-1715857171


MLA (The Modern Language Association) Style

Ahmad, Warda, and Muhammad Babar Imran. "Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments." Pakistan Journal of Nuclear Medicine 14.2 (2024), 38-40. Print. doi:10.24911/PJNMed.175-1715857171


APA (American Psychological Association) Style

Ahmad, W. & Imran, . M. B. (2024) Treatment Horizons for Advanced Radioiodine Refractory Thyroid Cancer: Recent Developments. Pakistan Journal of Nuclear Medicine, 14 (2), 38-40. doi:10.24911/PJNMed.175-1715857171




Most Viewed Articles
Most Accessed Articles

  • Determination of the optimum filter for 99mTc SPECT breast imaging using a wire mesh collimator
    Xianling Dong, M I Saripan, R Mahmud, S Mashohor, Aihui Wang
    Pak J Nucl Med. 2017; 7(1): 9-15
    » Abstract » doi: 10.24911/PJNMed.7.2

  • Behaviour of wedges for different field sizes and depths
    Sajjad Ahmed Memon, Naeem Ahmed Laghari, Fayaz Hussain Mangi
    Pak J Nucl Med. 2017; 7(1): 20-27
    » Abstract » doi: 10.24911/PJNMed.7.4

  • Clinical characteristics and long-term outcome of patients with differentiated carcinoma of thyroid with bone metastases: a retrospective study
    Sadaf Tufail Butt, Shazia Fatima, Noreen Marwat, Kahkashan Mir, Ayesha Ammar, Mohammad Faheem
    Pak J Nucl Med. 2017; 7(1): 34-37
    » Abstract » doi: 10.24911/PJNMed.7.6

  • Pre-operative cardiac risk stratification for noncardiac surgery in cancer patients using myocardial perfusion scintigraphy
    Iqbal Munir, Amrah Javaid, Khalid Nawaz, Mohammed Hathaf Al-Rowaily, Muaadh Abdualrehman Al-Asbahi
    Pak J Nucl Med. 2017; 7(1): 28-33
    » Abstract » doi: 10.24911/PJNMed.7.5

  • A brief review of targetted radionuclide therapies
    Mohammed Hathaf Al-Rowaily, Daniele Dondi, MarcoChinol, Iqbal Munir, Muaadh Abdualrehman Alasbahi
    Pak J Nucl Med. 2017; 7(1): 4-8
    » Abstract » doi: 10.24911/PJNMed.7.1

    •
    Most Downloaded
    Top Downloaded Articles

  • Behaviour of wedges for different field sizes and depths
    Sajjad Ahmed Memon, Naeem Ahmed Laghari, Fayaz Hussain Mangi
    Pak J Nucl Med. 2017; 7(1): 20-27
    » Abstract » doi: 10.24911/PJNMed.7.4

  • Determination of the optimum filter for 99mTc SPECT breast imaging using a wire mesh collimator
    Xianling Dong, M I Saripan, R Mahmud, S Mashohor, Aihui Wang
    Pak J Nucl Med. 2017; 7(1): 9-15
    » Abstract » doi: 10.24911/PJNMed.7.2

  • Characterization of SIEMENS Symbia T SPECT camera in Monte Carlo simulation environment
    Xianling Dong, Mahmud Iqbal Saripan, Rozi Mahmud, Syamsiah Mashohor, Aihui Wang,
    Pak J Nucl Med. 2018; 8(1): 18-26
    » Abstract » doi: 10.24911/PJNMed.175-1540569779

  • A historic review of the discovery of the medical uses of radioiodine
    Barbara Hertz, Pushan Bharadwaj, Bennett Greenspan
    Pak J Nucl Med. 2020; 10(1): 60-63
    » Abstract » doi: 10.24911/PJNMed.175-1582813482

  • A brief review of targetted radionuclide therapies
    Mohammed Hathaf Al-Rowaily, Daniele Dondi, MarcoChinol, Iqbal Munir, Muaadh Abdualrehman Alasbahi
    Pak J Nucl Med. 2017; 7(1): 4-8
    » Abstract » doi: 10.24911/PJNMed.7.1

    •

    About Pakistan Journal of Nuclear Medicine

    The Pakistan Journal of Nuclear Medicine (PJNM) is the official journal of the Pakistan Society of Nuclear Medicine and the first nuclear medicine journal ... Read more.



    For best results, please use Internet Explorer or Google Chrome.

    Contact Information

    Address: Pakistan Journal of Nuclear Medicine (PJNM), Room # D-115, D-Block, Department of Medical Sciences, Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, 45650, Pakistan.

    Email: pjnm@pieas.edu.pk, Phone: +92 51 9248706, Fax: +92 51 9248600

    Title Owner: Pakistan Society of Nuclear Medicine

    https://psnmed.com/

    Society Email: secretary@psnmed.com

    Address: Institute of Nuclear Medicine & Oncology (INMOL), New Campus Road, Lahore, Pakistan.

    Contact the publisher:

    contact@discoverpublish.com

    https://discoverpublish.com/ 

    Address: Discover STM Publishing Ltd, 82 Leslie's Arch, Old Quarter, Ballincollig, Cork, P31 RY62, Ireland.

    Hours:  M-F: 8:30am - 5:30pm

    Contact Emails:

    Journal Editorial Office: contact@pjnmed.com

    Billing Support:  contact@discoverpublish.com

    Technical Support: anastasiia.pavlenco@sofiafields.com - https://sofiafields.com/ 


     
    POLICIES & JOURNAL LINKS
    Author Login
    Reviewer Login
    Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information